US20040197361A1 - External preparation for the skin - Google Patents

External preparation for the skin Download PDF

Info

Publication number
US20040197361A1
US20040197361A1 US10/490,616 US49061604A US2004197361A1 US 20040197361 A1 US20040197361 A1 US 20040197361A1 US 49061604 A US49061604 A US 49061604A US 2004197361 A1 US2004197361 A1 US 2004197361A1
Authority
US
United States
Prior art keywords
dineopentanoate
skin
acid
treatment composition
oil
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
US10/490,616
Other languages
English (en)
Inventor
Nozomi Oguchi
Reiji Miyahara
Hiroyuki Kakoki
Takashi Ohmori
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Shiseido Co Ltd
Original Assignee
Shiseido Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Shiseido Co Ltd filed Critical Shiseido Co Ltd
Assigned to SHISEIDO COMPANY, LTD. reassignment SHISEIDO COMPANY, LTD. ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS). Assignors: KAKOKI, HIROYUKI, MIYAHARA, REIJI, OGUCHI, NOZOMI, OHMORI, TAKASHI
Publication of US20040197361A1 publication Critical patent/US20040197361A1/en
Priority to US12/074,394 priority Critical patent/US8404258B2/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/39—Derivatives containing from 2 to 10 oxyalkylene groups
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q1/00—Make-up preparations; Body powders; Preparations for removing make-up
    • A61Q1/02—Preparations containing skin colorants, e.g. pigments
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q1/00—Make-up preparations; Body powders; Preparations for removing make-up
    • A61Q1/02—Preparations containing skin colorants, e.g. pigments
    • A61Q1/04—Preparations containing skin colorants, e.g. pigments for lips
    • A61Q1/06—Lipsticks
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q1/00—Make-up preparations; Body powders; Preparations for removing make-up
    • A61Q1/12—Face or body powders for grooming, adorning or absorbing
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q1/00—Make-up preparations; Body powders; Preparations for removing make-up
    • A61Q1/14—Preparations for removing make-up
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q17/00—Barrier preparations; Preparations brought into direct contact with the skin for affording protection against external influences, e.g. sunlight, X-rays or other harmful rays, corrosive materials, bacteria or insect stings
    • A61Q17/04—Topical preparations for affording protection against sunlight or other radiation; Topical sun tanning preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/10—Washing or bathing preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q5/00—Preparations for care of the hair
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q5/00—Preparations for care of the hair
    • A61Q5/02—Preparations for cleaning the hair

Definitions

  • the present invention relates to a skin treatment composition that gives a refreshing sensation at the time of application and contains an oil component that is highly safe with low skin irritation.
  • Silicone oil has been added frequently to skin treatment compositions as an oil component that gives a refreshing sensation at the time of application.
  • an oil component that gives a refreshing sensation at the time of application has a small molecular weight and therefore a higher percutaneous absorption into the skin. As result, skin irritation such as tingling tends to become more pronounced.
  • the object of the present invention is to provide a skin treatment composition that has a particularly refreshing sensation at the time of application and is highly safe.
  • the present invention provides a skin treatment composition that characteristically contains an alkylene polyglycol dineopentanoate represented by the following general formula (1):
  • the present invention provides the aforementioned skin treatment composition wherein the compound represented by general formula (1) is tripropyleneglycol dineopentanoate represented by general formula (2):
  • n denotes an integer 2-4.
  • the oil component of general formula (1) used in the present invention is a prior art hydrocarbon type oil component.
  • a diester obtained by the condensation reaction between neopentyl chloride and polyethylene glycol it is preferable to use a diester obtained by the condensation reaction between neopentyl chloride and polyethylene glycol.
  • reaction solution obtained by the aforementioned synthesis scheme is rinsed several times with an ammonium chloride aqueous solution and subjected to extraction with ethyl acetate; the extract solution is concentrated and roughly purified by column chromatography, and further purified by vacuum distillation.
  • m denotes an integer 2-4. If m is 1, then the compound is volatile and malodorous. If m is five or more, the refreshing sensation at the time of application tends to be diminished.
  • alkylene polyglycol dineopentanoate that satisfies general formula (1) include diethyleneglycol dineopentanoate, triethyleneglycol dineopentanoate, tetraethyleneglycol dineopentanoate, dipropyleneglycol dineopentanoate, and tripropyleneglycol dineopentanoate.
  • Dipropyleneglycol dineopentanoate and tripropyleneglycol dineopentanoate are particularly preferable in terms of the sensation at the time of application; they provide a skin treatment composition that is particularly superior in terms of absorption into the skin and a sensation of permeation as well as being highly safe.
  • the blend ratio of the alkylene polyglycol dineopentanoate is not limited in particular. It is determined based on the formulation and the type of the product.
  • the blend ratio is 0.001-50.0% (mass percentage), preferably 0.1-30.0% (mass percentage), of the total composition.
  • the oil component of general formula (1) gives a refreshing sensation at the time of application, and is superior as an oil component to be blended into the base agent of skin treatment compositions such as cosmetics and quasi-drugs.
  • drugs and ultraviolet absorbents can be easily blended in when the base agent contains the oil component of general formula (1).
  • the skin treatment composition of the present invention is prepared by blending the aforementioned oil component into an existing skin treatment composition base agent.
  • ingredients used in skin treatment compositions can be blended as necessary in the skin treatment composition of the present invention; examples of such ingredients include powder ingredients, liquid fats and oils, solid fats and oils, waxes, hydrocarbons, higher fatty acids, higher alcohols, esters, silicones, anionic surfactants, cationic surfactants, ampholytic surfactants, nonionic surfactants, humectants, water-soluble polymers, thickeners, coating agents, ultraviolet absorbents, sequestering agents, lower alcohols, polyhydric alcohols, sugars, amino acids, organic amines, polymer emulsions, pH adjusting agents, skin nutrients, vitamins, antioxidants, antioxidation assistants, perfumes, and water; and the skin treatment composition can be prepared for the target formulation with a conventional method.
  • the skin treatment composition of the present invention can be prepared by blending the aforementioned essential ingredients and any one, two or more of the following ingredients.
  • Examples of the powder ingredients include inorganic powders (for example, talc, kaolin, mica, sericite, muscovite, phlogopite, synthetic mica, lepidolite, biotite, vermiculite, magnesium carbonate, calcium carbonate, aluminum silicate, barium silicate, calcium silicate, magnesium silicate, strontium silicate, tungstic acid metal salt, magnesium, silica, zeolite, barium sulfate, firing calcium sulfate (calcined gypsum), calcium phosphate, fluorine-apatite, hydroxy apatite, ceramic powder, metallic soaps (for example, myristic acid zinc, calcium palmitate, and aluminum stearate), and boron nitride); organic powders (for example, polyamide resin powder (nylon powder), polyethylene powder, poly methyl methacrylate powder, polystyrene powder, powders of the copolymer resin of styrene and acrylic acid,
  • liquid fats and oils examples include avocado oil, tsubaki oil, turtle fatty acid, macademia nut oil, corn oil, mink oil, olive oil, rapeseed oil, egg yolk oil, sesame oil, persic oil, wheat germ oil, sasanqua oil, castor oil, linseed oil, safflower oil, cotton seed oil, perilla oil, soybean oil, peanut oil, tea seed oil, Japanese nutmeg oil, rice bran oil, Chinese gimlet oil, Japan gimlet oil, jojoba oil, germ oil, and triglycerin.
  • solid fats and oils examples include cacao butter, coconut oil, hydrogenated coconut oil, palm oil, palm kernel oil, Japanese core wax nucleus oil, hydrogenated oil, Japanese core wax, and hydrogenated castor oil.
  • waxes examples include beeswax, candelilla wax, cotton wax, carnauba wax, bayberry wax, tree wax, whale wax, montan wax, bran wax, lanolin, kapok wax, lanolin acetate, liquid lanolin, sugar cane wax, lanolin fatty acid isopropyl ester, hexyl laurate, reduced lanolin, jojoba wax, hard lanolin, shellac wax, POE lanolin alcohol ether, POE lanolin alcohol acetate, POE cholesterol ether, lanolin fatty acid polyethylene glycol, and POE hydrogenated lanolin ethyl alcohol ether.
  • hydrocarbon oils examples include liquid petrolatum, ozocerite, squalane, pristane, paraffin, ceresin, squalene, petrolatum, and microcrystallin wax.
  • Examples of the higher fatty acids include lauric acid, myristic acid, palmitic acid, stearic acid, behenic acid, oleic acid, undecylenic acid, tall oil fatty acid, isostearic acid, linolic acid, linoleic acid, eicosapentaenoic acid (EPA), and docosahexaenoic acid (DHA).
  • Examples of the higher alcohols include straight chain alcohols (for example, lauryl alcohol, cetyl alcohol, stearyl alcohol, behenyl alcohol, myristyl alcohol, oleyl alcohol, and cetostearyl alcohol) and branched chain ethyl alcohols (for example, mono stearyl glycerin ether (batyl alcohol), 2-decyltetradecynol, lanolin alcohol, cholesterol, phytosterol, hexyl dodecanol, iso stearyl alcohol, and octyl dodecanol).
  • straight chain alcohols for example, lauryl alcohol, cetyl alcohol, stearyl alcohol, behenyl alcohol, myristyl alcohol, oleyl alcohol, and cetostearyl alcohol
  • branched chain ethyl alcohols for example, mono stearyl glycerin ether (batyl alcohol), 2-decyltetradecynol, lanolin alcohol, cholesterol
  • ester oils include isopropyl myristate, cetyl octanoate, octyl dodecyl myristate, isopropyl palmitate, butyl stearate, hexyl laurate, myristil myristate, decyl oleate, dimethyl hexyl decyl octanoate, cetyl lactate, myristil lactate, lanolin acetate, iso cetyl stearate, iso cetyl isostearate, cholesteryl hydroxy 12-stearate, di-2-ethylene glycol ethylhexanoate, dipentaerythritol fatty acid ester, n-alkylene glycol monoisostearate, neopentyl glycol dicaprate, diisostearyl malate, glyceryl di-2-heptylundecanoate, trimethylolpropane tri-2-
  • silicone oils examples include chain polysiloxanes (for example, dimethylpolysiloxane, methylphenyl polysiloxane, and diphenyl polysiloxane); ring polysiloxanes (for example, octamethylcyclotetrasiloxane, decamethyl cyclopenta siloxane, and dodecamethyl cyclohexa siloxane), silicone resins forming a three-dimensional network structure, silicone rubbers, and various modified polysiloxanes (amino-modified polysiloxane, polyether-modified polysiloxane, alkyl-modified polysiloxane, and and fluorine-modified polysiloxane).
  • chain polysiloxanes for example, dimethylpolysiloxane, methylphenyl polysiloxane, and diphenyl polysiloxane
  • ring polysiloxanes for example, octamethylcyclote
  • anionic surfactants include fatty acid soaps (for example, sodium laurate and sodium palmitate); higher alkyl sulfuric ester salts (for example, sodium lauryl sulfate and potassium laurylsulfate); alkylether sulfuric ester salts (for example, POE-triethanolamine laurylsulfate and sodium POE-lauryl sulfate); N-acyl sarcosinic acids (for example, sodium N-lauroyl sarcosinate); higher fatty acid ester sulfates (for example, hydrogenated coconut oil aliphatic acid glycerin sodium sulfate); N-acyl glutamates (for example, mono sodium N-lauroylglutamate, disodium N-stearoylglutamate, and sodium N-myristoyl-L-glutamate); sulfated oils (for example, turkey red oil); POE-alkylether carboxylic acid; POE-alkylaryl
  • Examples of the cationic surfactants include alkyltrimethylammonium salts (for example, stearyltrimethyl ammonium chloride and lauryltrimethyl ammonium chloride) alkylpyridinium salts (for example, cetylpyridinium chloride), distearyldimethylammonium chloride dialkyldimethylammonium salt; poly (N,N′-dimethyl-3,5-methylene piperidinium) chloride; alkyl quaternary ammonium salts; alkyl dimethylbenzyl ammonium salts; alkyl isoquinolinium salts; dialkylmorpholine salts; POE alkyl amines; alkyl amine salts; polyamine fatty acid derivatives; amylalcohol fatty acid derivatives; benzalkonium chloride; and benzethonium chloride.
  • alkyltrimethylammonium salts for example, stearyltrimethyl ammonium chloride and lauryltrimethyl ammonium
  • ampholytic surfactants examples include: imidazoline type ampholytic surfactants (for example, 2-undecyl-N,N,N-(hydroxyethyl carboxymethyl)-2-imidazoline sodium salt and 2-coco yl-2-imidazolinium hydroxide-1-carboxyethyloxy 2 sodium salt); and betaine type surfactants (for example, 2-heptadecyl-n-carboxymethyl-n-hydroxyethyl imidazolinium betaine, lauryldimethylaminoacetic acid betaine, alkyl betaine, amide betaine, and sulfobetaine).
  • imidazoline type ampholytic surfactants for example, 2-undecyl-N,N,N-(hydroxyethyl carboxymethyl)-2-imidazoline sodium salt and 2-coco yl-2-imidazolinium hydroxide-1-carboxyethyloxy 2 sodium salt
  • betaine type surfactants for example, 2-hept
  • lipophilic nonionic surface active agent examples include sorbitan fatty acid esters (for example, sorbitan mono oleate, sorbitan mono isostearate, sorbitan mono laurate, sorbitan mono palmitate, sorbitan mono stearate, sorbitan sesqui oleate, sorbitan trioleate, diglycerol sorbitan penta-2-ethylhexylate, diglycerol sorbitan tetra-2-ethylhexylate); glycerin polyglycerin aliphatic acids (for example, mono-cottonseed oil fatty acid glycerin, glyceryl monoerucate, glycerin sesquioleate, glyceryl monostearate, ⁇ , ⁇ ′-glyceryl oleate pyroglutamate, glyceryl mono stearate mono malate); propylene glycol fatty acid esters (for example,
  • hydrophilic nonionic surface active agents include: POE-sorbitan fatty acid esters (for example, POE-sorbitan monooleate, POE-sorbitan monostearate, POE-sorbitan monoolate, and POE-sorbitan tetraoleate); POE sorbitol fatty acid esters (for example, POE sorbitol monolaurate, POE-sorbitol monooleate, POE-sorbitolpentaoleate, and POE-sorbitol monostearate); POE-glycerin fatty acid esters (for example, POE-monooleates such as POE-glycerin monostearate, POE-glycerin monoisostearate, and POE-glycerin triisostearate); POE-fatty acid esters (for example, POE-distearate, POE-monodioleate, and ethylene glycol distearate); POE-sorbitan fatty acid
  • humectant examples include polyethylene glycol, propylene glycol, glycerin, 1,3-butylene glycol, xylitol, sorbitol, maltitol, chondroitin sulfate, hyaluronic acid, mucoitin sulfuric acid, charonic acid, atelocollagen, cholesteryl-12-hydroxy stearate, sodium lactate, bile salt, dl-pyrrolidone carboxylic acid salt, short chain soluble collagen, diglycerin (EO)PO adduct, chestnut rose fruit extract, yarrow extract, and sweet clover extract.
  • EO diglycerin
  • Examples of the natural water-soluble polymer include: plant-type polymers (for example, gum arabic, gum tragacanth, galactan, guar gum, carob gum, karaya gum, carrageenan, pectin, agar, quince seed (Cydonia oblonga), algae colloids (brown algae extract), starches (rice, corn, potato, and wheat), and glycyrrhizic acid); microorganism-type polymers (for example, xanthan gum, dextran, succinoglucan, and pullulan); and animal-type polymers (for example, collagen, casein, albumin, and gelatin).
  • plant-type polymers for example, gum arabic, gum tragacanth, galactan, guar gum, carob gum, karaya gum, carrageenan, pectin, agar, quince seed (Cydonia oblonga), algae colloids (brown algae extract), starches (rice, corn, potato, and wheat
  • Examples of the semisynthetic water-soluble polymers include: starch-type polymers (for example, carboxymethyl starch and methylhydroxypropyl starch); cellulosic polymers (for example, methyl cellulose, ethyl cellulose, methylhydroxypropyl cellulose, hydroxyethyl cellulose, cellulose sodium sulfate, hydroxypropyl cellulose, carboxymetyl-cellulose, sodium carboxymethyl cellulose, crystal cellulose, and cellulose powder); and alginic acid-type polymers (for example, sodium alginate and propyleneglycol alginate).
  • starch-type polymers for example, carboxymethyl starch and methylhydroxypropyl starch
  • cellulosic polymers for example, methyl cellulose, ethyl cellulose, methylhydroxypropyl cellulose, hydroxyethyl cellulose, cellulose sodium sulfate, hydroxypropyl cellulose, carboxymetyl-cellulose, sodium carboxymethyl cellulose, crystal
  • Examples of the synthetic water-soluble polymers include: vinyl polymers (for example, polyvinyl alcohol, polyvinyl methyl ether, polyvinylpyrrolidone, carboxy vinyl polymer); polyoxyethylene-type polymers (for example, a copolymer of polyethylene glycol 20,000, 40,000, or 60,000 and polyoxyethylene polyoxypropylene); acrylic polymers (for example, sodium polyacrylate, polyethylacrylate, and polyacrylamide); polyethyleneimine; and cationic polymers.
  • vinyl polymers for example, polyvinyl alcohol, polyvinyl methyl ether, polyvinylpyrrolidone, carboxy vinyl polymer
  • polyoxyethylene-type polymers for example, a copolymer of polyethylene glycol 20,000, 40,000, or 60,000 and polyoxyethylene polyoxypropylene
  • acrylic polymers for example, sodium polyacrylate, polyethylacrylate, and polyacrylamide
  • polyethyleneimine for example, sodium polyacrylate, polyethylacrylate, and
  • thickeners examples include: gum arabic, carrageenan, karaya gum, gum tragacanth, carob gum, quince seed (Cydonia oblonga), casein, dextrin, gelatin, sodium pectate, sodium arginate, methyl cellulose, ethyl cellulose, CMC, hydroxy ethyl cellulose, hydroxypropyl cellulose, PVA, PVM, PVP, sodium polyacrylate, carboxy vinyl polymer, locust bean gum, guar gum, tamarind gum, cellulose dialkyl dimethylammonium sulfate, xanthan gum, aluminum magnesium silicate, bentonite, hectorite, AlMg silicate (beagum), laponite, and silicic acid anhydride.
  • UV absorbents include the following.
  • PABA paraminobenzoic acid
  • PABA monoglycerin ester N, N-dipropoxy PABA ethyl ester, N,N-diethoxy PABA ethyl ester, N,N-dimethyl PABA ethyl ester, N, N-dimethyl PABA butyl ester, and N,N-dimethyl PABA ethyl ester.
  • amyl salicylate for example, amyl salicylate, mentyl salicylate, homo mentyl salicylate, octyl salicylate, phenyl salicylate, benzil salicylate, and p-isopropanol phenyl salicylate.
  • Examples of the sequestering agents include: 1-hydroxy ethane-1,1-diphosphonic acid, 1-hydroxy ethane-1,1-diphosphonic acid tetrasodium salt, disodium edetate, trisodium edetate, tetrasodium edetate, sodium citrate, sodium polyphosphate, sodium metaphosphate, gluconic acid, phosphoric acid, citric acid, ascorbic acid, succinic acid, and trisodium ethylenediaminehydroxyethyl triacetate.
  • Examples of the lower alcohols include ethanol, propanol, isopropanol, isobutanol, and t-butyl alcohol.
  • polyhydric alcohols examples include: dihydric alcohols (for example, ethylene glycol, propylene glycol, trimethylene glycol, 1,2-butylene glycol, 1,3-butylene glycol, tetramethylene glycol, 2,3-butylene glycol, pentamethylene glycol, 2-butene-1,4-diol, hexylene glycol, and octylene glycol); trihydric alcohols (for example, glycerin and trimethylolpropane); tetrahydric alcohols (for example, pentaerythritol such as 1,2,6-hexanetriol) pentahydric alcohols (for example, xylitol); hexahydric alcohols (for example, sorbitol, mannitol); polyhydric alcohol polymers (for example, diethylene glycol, dipropylene glycol, triethylene glycol, polypropylene glycol, tetraethylene glycol, diglycer
  • Examples of the monosaccharides include: trioses (for example, D-glyceryl aldehyde and dihydroxyacetone); tetroses (for example, D-etythrose, D-erythrulose, D-threose, and erythritol); pentoses (for example, L-arabinose, D-xylose, L-lyxose, D-arabinose, D-ribose, D-ribulose, D-xylulose, and L-xylulose); hexoses (for example, D-glucose, D-talose, D-psicose, D-galactose, D-fructose, L-galactose, L-mannose, and D-tagatose); heptoses (for example, aldoheptose and heprose); octoses (for example, octurose); deoxysugars
  • oligosaccharides examples include sucrose, umbelliferose, lactose, planteose, isolignoses, ⁇ , ⁇ -trehalose, raffinose, lignoses, umbilicine, stachyose and verbascose.
  • polysaccharides examples include cellulose, quince seed, chondroitin sulfate, starch, galactan, dermatan sulfate, glycogen, gum arabic, heparan sulfate, hyaluronic acid, traganth gum, keratan sulfate, chondroitin, xanthan gum, mucoitin sulfuric acid, guar gum, dextran, kerato sulfate, locustbean gum, succinoglucane, and charonic acid.
  • amino acids examples include neutral amino acids (for example, threonine and cysteine) and basic amino acids (for example, hydroxylysine).
  • amino acid derivatives include sodium acyl sarcosinate (sodium N-lauroyl sarcosinate), acyl glutamate, acyl ⁇ -alanine sodium, glutathione, and pyrrolidone carboxylic acid.
  • organic amines examples include monoethanolamine, diethanolamine, triethanolamine, morpholine, triisopropanolamine, 2-amino-2-carbinyl-1,3-propanediol, and 2-amino-2-carbinyl-1-propanol.
  • Examples of the high polymer emulsions include acrylic resin emulsions, ethyl polyacrylate emulsions, acryl resin liquids, polyacrylic alkyl ester emulsions, polyvinyl acetate resin emulsions, and natural rubber latex.
  • pH adjustment agents examples include buffers such as lactic acid-sodium lactate, citric acid-sodium citrate, and succinic acid-sodium succinate.
  • vitamins A, B1, B2, B6, C and E examples include vitamins A, B1, B2, B6, C and E as well as their derivatives, pantothenic acid and its derivatives, and biotin.
  • antioxidants examples include tocopherols, dibutyl hydroxytoluene, butyl hydroxyanisole, and gallic ester.
  • antioxidation auxiliary agents examples include phosphoric acid, citric acid, ascorbic acid, maleic acid, malonic acid, succinic acid, fumaric acid, cephalin, hexameta phosphate, phytic acid, and ethylene diamine tetraacetic acid.
  • antiseptics methylparaben, ethylparaben, butylparaben, and phenoxyethanol
  • anti-inflammatory agents for example, glycyrrhizic acid derivatives, glycyrrhetinic acid derivatives, salicylic acid derivatives, hinokitiol, zinc oxide, and allantoin
  • whitening agents for example, creeping saxifrage extract and arbutin
  • various extracts for example, Phellodendri Cortex, goldthread, lithospermum root, Paeonia lactiflora, Swertia japonica, Birch, sage, loquat, carrot, aloe,.
  • Any formulation can be used for the skin treatment composition of the present invention.
  • the product form of the skin treatment composition of the present invention is also arbitrary.
  • a skin treatment composition having an ultraviolet absorbent or various drugs is also preferable.
  • blend ratios are in mass-percentage (%) units unless specified otherwise.
  • the test was conducted using a Finn Chamber (8 mm in diameter) with 24 hour-occlusion.
  • Test subjects were 46 male and female healthy volunteers (33 males and 13 females) whose ages range from 22 to 59 (average 42); 0.03 ml of the original specimen of alkylene polyglycol dineopentanoate was applied on the bent side of the forearm of the test subjects for 24 hours.
  • the application site was secured with an elastic bandage; three hours after the removal of the bandage and the adhesive plaster the first evaluation (after-24-hours evaluation) was conducted according to the evaluation criteria of Table 1, and 24 hours later another evaluation (after-48-hours evaluation) was conducted with the same criteria.
  • alkylene polyglycol dineopentanoate used here was prepared as follows: using the synthesis scheme described below, neopentyl chloride and polyethylene glycol were reacted for six hours at 0° C. to room temperature, HCl was removed, and a diester form was prepared by means of a condensation reaction.
  • polyethylene glycols used here are diethylene glycol, triethylene glycol, tetraethylene glycol, dipropylene glycol, and tripropylene glycol.
  • reaction solution was rinsed several times with an ammonium chloride aqueous solution and subjected to extraction with ethyl acetate; the extract solution was concentrated and roughly purified by column chromatography, and further purified by vacuum distillation. The purity of the preparation for use was 99% or higher.
  • Table 2 shows that alkylene polyglycol dineopentanoate exhibits low irritation.
  • Table 3 Examples Ingredients 4 5 6 7 Dineopentanoic 0.001 0.1 1.0 5.0 acidtripropylene glycol Sodium hexamethaphosphate 0.01 0.01 0.01 0.01 0.01 Trisodium edetate 0.03 0.03 0.03 1,3-butylene glycol 5 5 5 5 Potassium hydroxide 0.1 0.1 0.1 0.1 0.1 Carboxyvinyl polymer 0.1 0.1 0.1 0.1 Phenoxy ethanol 0.15 0.15 0.15 Purified water Balance Balance Balance Balance Evaluation (1): Refreshing ⁇ ⁇ ⁇ ⁇ sensation on the skin Evaluation (2): Permeating ⁇ ⁇ ⁇ ⁇ sensation on the skin Evaluation (3): ⁇ ⁇ ⁇ ⁇ Non-stickiness on the skin
  • Oil phase A and water phase B were each heated up to 70° C. to be dissolved completely.
  • the A phase was added to the B phase, followed by emulsification by means of an emulsifier.
  • the emulsion was cooled by a heat exchanger to obtain cream.
  • the obtained cream exhibited superior smoothness, no stickiness, and sustained moisture retention.
  • Cream was obtained in the same manner as in Example 11. The obtained cream exhibited superior smoothness, no stickiness, and sustained moisture retention.
  • the oil phase and the water phase were each mixed and dissolved.
  • the water phase was added to the oil phase, followed by emulsification by means of a homogenizer.
  • the obtained emulsion exhibited superior smoothness, no stickiness, and sustained moisture retention.
  • the alcohol phase A was added to the water phase B, followed by solubilization to obtain a lotion.
  • the obtained lotion exhibited superior smoothness, no stickiness, and sustained moisture retention.
  • the powder components, the oil components, and the crushed liquid titanated mica in the recipe were dispersed/mixed in ethyl alcohol by using a sand grinder mill having 3 mm-diameter zirconia beads. After distilling ethyl alcohol, the mixture was. crushed once with a pulverizer; it was then packed in a container (inner tray made of resin) and molded by means of a dry press with a prior art method to obtain solid powdery foundation. The obtained solid powdery foundation exhibited a superior refreshing sensation.
  • the cleansing oil was obtained by mixing and dissolving.
  • the obtained cleansing oil exhibited superior smoothness, no stickiness, and sustained moisture retention.
  • the aforementioned components were mixed with a conventional method to prepare a hair shampoo having a pearly look. Head hair washed with the obtained hair shampoo was superior in terms of tactile sensation of the hair during and after use, especially in terms of smoothness, and it was a hair cleaning agent that exhibited good foaming and cleansing effects even if a styling agent had been applied on the hair.
  • the aforementioned components were mixed with a conventional method to prepare a clear hair shampoo. Head hair washed with the obtained hair shampoo was superior in tactile sensation of the hair during and after use, especially in terms of smoothness, and it was a hair cleaning agent that exhibited good foaming and cleansing effects even if a styling agent had been applied on the hair.
  • This hair rinse gave a moist texture to the hair without stickiness, and improvesed the smooth and supple texture, thus giving superior sensation during use.
  • This hair treatment cream gave moist texture to the hair without stickiness, and improved the smooth and supple texture, thus giving superior sensation during use.
  • This hair rinse gave a moist texture to the hair without stickiness, and improved the smooth and supple texture, thus giving superior sensation during use.
  • This hair treatment cream gives moist texture to the hair without stickiness, and improves the smooth and supple texture, thus giving superior sensation during use.
  • the aforementioned components were emulsified by an emulsifier with a conventional method to obtain a make cleansing gel.
  • the obtained make cleansing gel was easy to rinse off, and exhibited superior effects in terms of usability, safety, and the cosmetic-removal effect.
  • the aforementioned components were emulsified by an emulsifier with a conventional method to obtain a make cleansing gel.
  • the obtained make cleansing gel was easy to rinse off, and exhibited superior effects in terms of usability, safety, and the cosmetic-removal effect.
  • the aforementioned components were stirred and dissolved with a conventional method, followed by cooling by a heat exchanger to obtain a body shampoo.
  • the obtained body shampoo was easy to rinse off, and exhibited superior effects in terms of usability, safety, and the cosmetic-removal effect.
  • the present invention can provide a skin treatment composition that gives a refreshing sensation at the time of application and contains an oil component that is highly safe with low skin irritation.

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Dermatology (AREA)
  • Emergency Medicine (AREA)
  • Birds (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Cosmetics (AREA)
US10/490,616 2001-09-26 2002-09-24 External preparation for the skin Abandoned US20040197361A1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
US12/074,394 US8404258B2 (en) 2001-09-26 2008-03-04 External preparation for the skin

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP2001293922 2001-09-26
JP2001-293922 2001-09-26
PCT/JP2002/009755 WO2003026698A1 (fr) 2001-09-26 2002-09-24 Preparation externe pour la peau

Related Child Applications (1)

Application Number Title Priority Date Filing Date
US12/074,394 Division US8404258B2 (en) 2001-09-26 2008-03-04 External preparation for the skin

Publications (1)

Publication Number Publication Date
US20040197361A1 true US20040197361A1 (en) 2004-10-07

Family

ID=19115613

Family Applications (2)

Application Number Title Priority Date Filing Date
US10/490,616 Abandoned US20040197361A1 (en) 2001-09-26 2002-09-24 External preparation for the skin
US12/074,394 Expired - Fee Related US8404258B2 (en) 2001-09-26 2008-03-04 External preparation for the skin

Family Applications After (1)

Application Number Title Priority Date Filing Date
US12/074,394 Expired - Fee Related US8404258B2 (en) 2001-09-26 2008-03-04 External preparation for the skin

Country Status (8)

Country Link
US (2) US20040197361A1 (enrdf_load_stackoverflow)
EP (1) EP1430905B1 (enrdf_load_stackoverflow)
JP (1) JP3673924B2 (enrdf_load_stackoverflow)
KR (1) KR100826503B1 (enrdf_load_stackoverflow)
CN (1) CN100563713C (enrdf_load_stackoverflow)
DE (1) DE60223576T2 (enrdf_load_stackoverflow)
TW (1) TWI314057B (enrdf_load_stackoverflow)
WO (1) WO2003026698A1 (enrdf_load_stackoverflow)

Cited By (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20070190003A1 (en) * 2003-07-25 2007-08-16 Pascal Arnaud Cosmetic composition comprising a particular ester, and uses thereof
US20080279885A1 (en) * 2005-10-27 2008-11-13 Pele Nova Biotechnologia S.A. Topical Formulation Containing Latex of Fraction Thereof, and Cosmetic Treatment Method
US20100166684A1 (en) * 2008-12-25 2010-07-01 Kokyu Alcohol Kogyo Co., Ltd. Water-in-oil type emulsified cosmetic
US9622951B2 (en) 2012-10-29 2017-04-18 The Procter & Gamble Company Personal care compositions
US20180271755A1 (en) * 2014-10-31 2018-09-27 Shiseido Company, Ltd. Oil-in-water emulsion sunscreen cosmetic

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP4515109B2 (ja) * 2004-02-18 2010-07-28 株式会社資生堂 脂質分解促進効果を有する皮膚外用剤および繊維
EP1781282A4 (en) * 2004-07-23 2010-09-01 Dpi Solutions Inc COMPOSITION FOR STABILIZING VITAMIN C IN WATER PHASE AND THIS USE METHOD FOR STABILIZING VITAMIN C
US8022026B2 (en) * 2005-12-20 2011-09-20 S.C. Johnson & Son, Inc. Odor elimination composition comprising triethylene glycol for use on soft surfaces
WO2007074675A1 (ja) * 2005-12-27 2007-07-05 Fancl Corporation 油性液状クレンジング用組成物
JP2008214267A (ja) * 2007-03-05 2008-09-18 Shiseido Co Ltd 粉末化粧料の製造方法
JP5243078B2 (ja) * 2008-03-31 2013-07-24 株式会社 資生堂 高極性油配合水中油型超微細エマルション外用剤及びその水中油型超微細エマルション外用剤の製造方法
JP4560122B2 (ja) 2008-12-18 2010-10-13 株式会社資生堂 酸化チタン分散体およびそれを配合した化粧料
KR20110122696A (ko) 2009-03-03 2011-11-10 닛신 오일리오그룹 가부시키가이샤 화장료, 그 제조방법, 화장료용 조성물, 상기 화장료용 조성물을 포함하는 화장료와 그 제조방법 및 공업용 클렌저
CN101889966B (zh) * 2010-06-21 2011-12-07 金奇集团金奇日化有限公司 一种茶油防裂霜组合物的制备方法及制品
JP6465701B2 (ja) * 2015-03-10 2019-02-06 株式会社コーセー 油性固形化粧料
JP6468891B2 (ja) * 2015-03-10 2019-02-13 株式会社コーセー 油性メイクアップ化粧料
CN106631805A (zh) * 2016-12-30 2017-05-10 山东万图高分子材料股份有限公司 一种非苯类软化剂及其制备方法
JP7356228B2 (ja) * 2018-01-31 2023-10-04 株式会社コーセー 組成物
AU2022308665B2 (en) * 2021-07-09 2025-01-16 Colgate-Palmolive Company Solid cleansing compositions and methods for the same
WO2024262323A1 (ja) * 2023-06-19 2024-12-26 株式会社 資生堂 洗浄料

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4673569A (en) * 1985-02-12 1987-06-16 Faberge Incorporated Mousse hair composition

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS503294B1 (enrdf_load_stackoverflow) * 1970-06-23 1975-02-03
US3799878A (en) * 1970-07-21 1974-03-26 Maruzen Oil Co Ltd Method of hydraulic transmission of power and hydraulic fluid compositions therefor
DE2257546A1 (de) * 1971-11-29 1973-06-07 Dow Chemical Co Hydraulik-fluessigkeit
JPH04183789A (ja) * 1990-11-19 1992-06-30 Sanken Kako Kk フロン圧縮機用潤滑油
US6280519B1 (en) * 1998-05-05 2001-08-28 Exxon Chemical Patents Inc. Environmentally preferred fluids and fluid blends
KR20020063914A (ko) * 1999-12-20 2002-08-05 코니스 프랑스, 에스.에이. 화장용 및/또는 약학용 제제
JP2002302469A (ja) * 2001-03-30 2002-10-18 Shiseido Co Ltd ネオペンタン酸アルキルポリグリコール
JP4163862B2 (ja) * 2001-03-30 2008-10-08 株式会社資生堂 皮膚外用剤

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4673569A (en) * 1985-02-12 1987-06-16 Faberge Incorporated Mousse hair composition

Cited By (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20070190003A1 (en) * 2003-07-25 2007-08-16 Pascal Arnaud Cosmetic composition comprising a particular ester, and uses thereof
US20080279885A1 (en) * 2005-10-27 2008-11-13 Pele Nova Biotechnologia S.A. Topical Formulation Containing Latex of Fraction Thereof, and Cosmetic Treatment Method
US8071106B2 (en) * 2005-10-27 2011-12-06 Pele Nova Biotechnologia S.A. Topical formulation containing latex of fraction thereof, and cosmetic treatment method
US20100166684A1 (en) * 2008-12-25 2010-07-01 Kokyu Alcohol Kogyo Co., Ltd. Water-in-oil type emulsified cosmetic
US9504633B2 (en) * 2008-12-25 2016-11-29 Kokyu Alcohol Kogyo Co., Ltd. Water-in-oil type emulsified cosmetic
US9622951B2 (en) 2012-10-29 2017-04-18 The Procter & Gamble Company Personal care compositions
US20180271755A1 (en) * 2014-10-31 2018-09-27 Shiseido Company, Ltd. Oil-in-water emulsion sunscreen cosmetic
US11806412B2 (en) * 2014-10-31 2023-11-07 Shiseido Company, Ltd. Oil-in-water emulsion sunscreen cosmetic

Also Published As

Publication number Publication date
WO2003026698A1 (fr) 2003-04-03
EP1430905B1 (en) 2007-11-14
KR100826503B1 (ko) 2008-05-02
EP1430905A4 (en) 2006-06-14
KR20040036689A (ko) 2004-04-30
JPWO2003026698A1 (ja) 2005-01-06
DE60223576D1 (de) 2007-12-27
DE60223576T2 (de) 2008-10-23
US8404258B2 (en) 2013-03-26
CN100563713C (zh) 2009-12-02
CN1535162A (zh) 2004-10-06
EP1430905A1 (en) 2004-06-23
TWI314057B (enrdf_load_stackoverflow) 2009-09-01
US20080293811A1 (en) 2008-11-27
JP3673924B2 (ja) 2005-07-20

Similar Documents

Publication Publication Date Title
US8404258B2 (en) External preparation for the skin
EP2181697B1 (en) Oil-in-water emulsion type sunscreen preparation
EP1153602B1 (en) Skin preparations for external use comprising diethoxyethyl succinate
KR101407750B1 (ko) 피부외용제
KR101485614B1 (ko) 피부용 또는 모발용 조성물
US5849272A (en) Ultraviolet absorbing composition
US20060099161A1 (en) Skin preparations for external use
US20110098231A1 (en) Skin Cosmetic
US7445790B2 (en) External preparations for skin
US20100075882A1 (en) External Skin Preparation And Skin Cleanser
EP2474302B1 (en) Sunscreen cosmetic composition containing ultraviolet absorber
JP3495217B2 (ja) コラーゲン産生促進剤
JP4601056B2 (ja) シロキサンエステル化合物、皮膚外用剤油分又は毛髪化粧料油分及びこれを配合した皮膚外用剤又は毛髪化粧料
JP3695710B2 (ja) 皮膚外用剤
JP2001019618A (ja) 美白剤及びこれを配合した皮膚外用剤
JP2004018415A (ja) 油中水型乳化化粧料
EP4599819A1 (en) Gel composition and oil-in-water-type composition
JP7037780B2 (ja) 美白剤

Legal Events

Date Code Title Description
AS Assignment

Owner name: SHISEIDO COMPANY, LTD., JAPAN

Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNORS:OGUCHI, NOZOMI;MIYAHARA, REIJI;KAKOKI, HIROYUKI;AND OTHERS;REEL/FRAME:015432/0988

Effective date: 20040204

STCB Information on status: application discontinuation

Free format text: ABANDONED -- FAILURE TO RESPOND TO AN OFFICE ACTION